购物车
全部删除
您的购物车当前为空
别名 艾普奈珠单抗, ALD-403, ALD403
Eptinezumab是一种靶向CGRP(降钙素基因相关肽)的人源化单克隆抗体,能够阻止CGRP与受体相结合,可用于预防偏头痛。

为众多的药物研发团队赋能,
让新药发现更简单!
Eptinezumab是一种靶向CGRP(降钙素基因相关肽)的人源化单克隆抗体,能够阻止CGRP与受体相结合,可用于预防偏头痛。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 993 | 现货 | |
| 5 mg | ¥ 2,980 | 现货 | |
| 10 mg | ¥ 4,290 | 现货 | |
| 25 mg | ¥ 6,690 | 现货 | |
| 50 mg | ¥ 8,870 | 现货 |
Eptinezumab 相关产品
| 产品描述 | Eptinezumab is a humanised monoclonal antibody targeting CGRP (calcitonin gene-related peptide), which prevents CGRP binding to its receptor and may be used for migraine prevention. |
| 别名 | 艾普奈珠单抗, ALD-403, ALD403 |
| CAS No. | 1644539-04-7 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
评论内容